Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Plos One|December 24, 2015
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis PatientsAndrius Kavaliunas, Michael Wiberg, Petter Tinghög, et al.
British Journal of Clinical Pharmacology|December 31, 2013
Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adultsKatja M Hakkarainen, Hanna Gyllensten, Anna K Jönsson, et al.
BMC Public Health|July 20, 2018
Increasing return-to-work among people on sick leave due to common mental disorders: design of a cluster-randomized controlled trial of a problem-solving intervention versus care-as-usual conducted in the Swedish primary health care system (PROSA)Elisabeth Björk Brämberg, Kristina Holmgren, Ute Bültmann, et al.
ESC Heart Failure|November 8, 2023
Self-efficacy and healthcare costs in patients with chronic heart failure or chronic obstructive pulmonary diseaseElin Blanck, Laura Pirhonen Nørmark, Andreas Fors, et al.
Plos One|January 13, 2017
Income in Multiple Sclerosis Patients with Different Disease PhenotypesAndrius Kavaliunas, Ali Manouchehrinia, Virginija Danylaite Karrenbauer, et al.
Health Policy OPEN|June 29, 2023
The cost-effectiveness of person-centred care provided to patients with chronic heart failure and/or chronic obstructive pulmonary diseaseLaura Pirhonen, Hanna Gyllensten, Elisabeth Hansson Olofsson, et al.
Pharmacoeconomics - Open|March 3, 2019
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled TrialLaura Pirhonen, Kristian Bolin, Elisabeth Hansson Olofsson, et al.
Ophthalmology Science|August 26, 2024
Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-AnalysisUlrika Sjöbom, Tove Hellqvist, Jhangir Humayun, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 11, 2017
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working ageHanna Gyllensten, Michael Wiberg, Kristina Alexanderson, et al.
Plos One|March 19, 2014
Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adultsHanna Gyllensten, Katja M Hakkarainen, Staffan Hägg, et al.
Pageof 9